Project Abstract

Abstract
This research study aims to investigate the impact of probiotics on gut health in individuals diagnosed with Irritable Bowel Syndrome (IBS) through a randomized controlled trial. Irritable Bowel Syndrome is a common gastrointestinal disorder characterized by abdominal pain, bloating, and altered bowel habits. Probiotics, live bacteria and yeasts believed to have health benefits when consumed, have shown promise in managing IBS symptoms by modulating the gut microbiota and promoting a healthy gut environment. The study will involve a randomized controlled trial design, where participants diagnosed with IBS will be randomly assigned to either a probiotics intervention group or a control group. The intervention group will receive a specific probiotic supplement daily for a specified duration, while the control group will receive a placebo. Various outcomes related to gut health, including symptom severity, bowel habits, quality of life, and gut microbiota composition, will be assessed before and after the intervention period. Chapter 1 of the study will provide an introduction to the research topic, background information on IBS and probiotics, the problem statement highlighting the need for further investigation, research objectives outlining the specific aims of the study, limitations and scope of the research, significance of the study in advancing knowledge in the field, structure of the research, and definitions of key terms used in the study. Chapter 2 will present a comprehensive literature review on probiotics, gut health, and their potential impact on IBS symptoms. The review will include current research findings, theoretical frameworks, and gaps in the existing literature that justify the need for this study. Chapter 3 will detail the research methodology, including the study design, participant recruitment and selection criteria, intervention protocol, outcome measures, data collection procedures, statistical analysis plan, ethical considerations, and potential challenges in conducting the research. Chapter 4 will present a detailed discussion of the research findings, including the effects of probiotics on gut health parameters in individuals with IBS, comparisons between the intervention and control groups, implications of the results, and potential future research directions. Chapter 5 will provide a conclusion and summary of the research, highlighting the key findings, implications for clinical practice, limitations of the study, and recommendations for further research in this area. Overall, this study aims to contribute to the growing body of evidence on the use of probiotics as a potential therapeutic intervention for individuals with Irritable Bowel Syndrome to improve gut health and quality of life.

Project Overview